SE8104456L - Hydantoinderivat, sett for framstellning derav och lekemedel innehallande dem - Google Patents

Hydantoinderivat, sett for framstellning derav och lekemedel innehallande dem

Info

Publication number
SE8104456L
SE8104456L SE8104456A SE8104456A SE8104456L SE 8104456 L SE8104456 L SE 8104456L SE 8104456 A SE8104456 A SE 8104456A SE 8104456 A SE8104456 A SE 8104456A SE 8104456 L SE8104456 L SE 8104456L
Authority
SE
Sweden
Prior art keywords
hydantoin derivatives
atom
same
preparation
hydrogen atom
Prior art date
Application number
SE8104456A
Other languages
English (en)
Other versions
SE454778B (sv
Inventor
K Ueda
S Tanaka
T Kunii
K Kagei
T Sato
H Ono
I Ohtsuka
M Kawase
T Ohgoh
T Wakabayashi
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of SE8104456L publication Critical patent/SE8104456L/sv
Publication of SE454778B publication Critical patent/SE454778B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems
SE8104456A 1980-07-21 1981-07-20 Hydantoinderivat, sett for framstellning derav och farmaceutisk komposition innehallande dem SE454778B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55098695A JPS5745185A (en) 1980-07-21 1980-07-21 Hydantoin derivative and its preparation

Publications (2)

Publication Number Publication Date
SE8104456L true SE8104456L (sv) 1982-01-22
SE454778B SE454778B (sv) 1988-05-30

Family

ID=14226632

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8104456A SE454778B (sv) 1980-07-21 1981-07-20 Hydantoinderivat, sett for framstellning derav och farmaceutisk komposition innehallande dem

Country Status (14)

Country Link
US (3) US4540704A (sv)
JP (1) JPS5745185A (sv)
BE (1) BE889698A (sv)
CA (1) CA1167447A (sv)
CH (1) CH651568A5 (sv)
DE (1) DE3128606A1 (sv)
DK (1) DK157301C (sv)
ES (1) ES8205398A1 (sv)
FR (1) FR2487353B1 (sv)
GB (1) GB2080304B (sv)
IT (1) IT1194143B (sv)
NL (1) NL8103432A (sv)
PH (1) PH17460A (sv)
SE (1) SE454778B (sv)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556670A (en) * 1982-12-06 1985-12-03 Pfizer Inc. Spiro-3-hetero-azolones for treatment of diabetic complications
GB2132484B (en) * 1982-12-23 1986-07-02 Tampax Ltd Tampon applicator
US4474967A (en) * 1983-04-27 1984-10-02 Pfizer Inc. 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione
ATE37371T1 (de) * 1984-08-20 1988-10-15 Pfizer Verfahren zur herstellung asymmetrischer hydantoine.
US5066659A (en) * 1984-10-30 1991-11-19 Pfizer Inc. Spiro-heteroazalones for treatment of diabetic complications
JPS62155269A (ja) * 1984-12-29 1987-07-10 Kaken Pharmaceut Co Ltd ベンゾフラン誘導体
JPH0772190B2 (ja) * 1985-02-26 1995-08-02 エーザイ株式会社 ヒダントイン誘導体
JPS61200991A (ja) * 1985-03-04 1986-09-05 Sanwa Kagaku Kenkyusho:Kk スピロ―３―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤
US4575507A (en) * 1985-05-29 1986-03-11 Pfizer Inc. Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use
US4762839A (en) * 1985-06-06 1988-08-09 Tanabe Seiyaku Co., Ltd. Quinazolinone copmpounds useful for the prophyloxis and treatment of diabetic complications
WO1987004344A1 (en) * 1986-01-17 1987-07-30 Pfizer Inc. Hydroxyacetic acid derivatives for the treatment of diabetic complications
JPS6357588A (ja) * 1986-08-28 1988-03-12 Sanwa Kagaku Kenkyusho Co Ltd ヒダントイン誘導体、その塩並びに該化合物を有効成分とする糖尿病合併症の予防及び治療剤
DE3769066D1 (de) * 1986-08-28 1991-05-08 Sanwa Kagaku Kenkyusho Co Hydantoin-derivate zur behandlung von komplikationen bei diabetes.
JPS63132889A (ja) * 1986-11-21 1988-06-04 Tanabe Seiyaku Co Ltd キナゾリノン誘導体
US4841079A (en) * 1987-08-07 1989-06-20 Pfizer, Inc. Process for the production of asymmetric hydantoins
JP2708507B2 (ja) * 1988-04-07 1998-02-04 株式会社三和化学研究所 （ｄ）‐６‐フルオロ‐２，３‐ジヒドロ‐２’，５’‐ジオキソ‐スピロ［４Ｈ‐１‐ベンゾピラン‐４，４’‐イミダゾリジン］‐２‐カルボキサミド誘導体、これらの製法及び用途
US4987231A (en) * 1989-08-04 1991-01-22 Pfizer Inc. Optical resolution method for 3R-(3-carboxybenzyl)-6-(5-fluoro-2-benzothiazolyl)methoxy-4R-chromanol
US5164391A (en) * 1989-09-20 1992-11-17 Sanwa Kagaku Kenkyusho Co., Ltd. Hydantoin derivatives for treating complications of diabetes and circulatory diseases
US4980357A (en) * 1990-03-01 1990-12-25 Pfizer Inc. Azolidinedione derivatives
WO1993005045A1 (en) * 1991-08-28 1993-03-18 The Upjohn Company Spirocyclic benzopyran imidazolines
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US7386401B2 (en) * 1994-11-21 2008-06-10 Phatrat Technology, Llc Helmet that reports impact information, and associated methods
US6539336B1 (en) * 1996-12-12 2003-03-25 Phatrat Technologies, Inc. Sport monitoring system for determining airtime, speed, power absorbed and other factors such as drop distance
US6166041A (en) * 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) * 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
NZ516696A (en) * 1997-04-15 2003-08-29 Csir Pharmaceutical compositions having appetite suppressant activity
US6077849A (en) * 1998-04-02 2000-06-20 Merck & Co., Inc. Antidiabetic agents
AU754989B2 (en) * 1998-11-16 2002-11-28 Nippon Zoki Pharmaceutical Co., Ltd. A therapeutic agent for intractable vasculitis
GB2396815B (en) * 1999-10-27 2004-09-08 Phytopharm Plc A composition comprising a pregnenone derivative and an NSAID
GB2363985B (en) * 2000-06-30 2004-09-29 Phytopharm Plc Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
AU2002215160A1 (en) 2000-11-30 2002-06-11 Pfizer Products Inc. Combination of gaba agonists and aldose reductase inhibitors
US20110092566A1 (en) * 2004-11-19 2011-04-21 Srivastava Satish K Treatment of cancer with aldose reductase inhibitors
US8158667B2 (en) 2006-08-21 2012-04-17 Kador Peter F Topical treatment of cataracts in dogs
US8877717B2 (en) 2007-03-12 2014-11-04 Zadec Aps Anti-diabetic extract of rooibos
WO2008118844A1 (en) 2007-03-23 2008-10-02 The Board Of Regents Of The University Of Texas System Methods involving aldose reductase inhibitors
US20090270490A1 (en) * 2008-04-24 2009-10-29 The Board Of Regents Of The University Of Texas System Methods involving aldose reductase inhibition
WO2010065024A1 (en) * 2008-12-05 2010-06-10 Kador Peter F Topical treatment of cataracts in dogs
AR075854A1 (es) 2009-03-13 2011-05-04 Vitae Pharmaceuticals Inc Inhibidores de beta- secretasa
EP2539322B1 (en) 2010-02-24 2014-01-01 Vitae Pharmaceuticals, Inc. Inhibitors of beta-secretase
EP2654749B1 (en) 2010-12-23 2017-05-10 The Board of Regents of The University of Texas System Methods for treating copd
TWI557112B (zh) 2012-03-05 2016-11-11 百靈佳殷格翰國際股份有限公司 β－分泌酶抑制劑
TW201422592A (zh) 2012-08-27 2014-06-16 Boehringer Ingelheim Int β－分泌酶抑制劑
US9290477B2 (en) 2012-09-28 2016-03-22 Vitae Pharmaceuticals, Inc. Inhibitors of β-secretase

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US418729A (en) * 1890-01-07 Cultivator
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents
US4147795A (en) * 1977-02-11 1979-04-03 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4176185A (en) * 1979-01-22 1979-11-27 Pfizer Inc. Spiro-quinolylhydantoins
US4181729A (en) * 1979-03-21 1980-01-01 Pfizer Inc. Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives
FR2455046A1 (fr) * 1979-04-25 1980-11-21 Science Union & Cie Nouvelles hydantoines, leur procede de preparation et leur emploi comme medicament

Also Published As

Publication number Publication date
US4540704A (en) 1985-09-10
SE454778B (sv) 1988-05-30
US4780472A (en) 1988-10-25
BE889698A (fr) 1982-01-22
DE3128606A1 (de) 1982-05-13
IT1194143B (it) 1988-09-14
JPS6332793B2 (sv) 1988-07-01
ES504103A0 (es) 1982-06-01
DK323281A (da) 1982-02-26
CA1167447A (en) 1984-05-15
GB2080304B (en) 1984-02-01
PH17460A (en) 1984-08-29
ES8205398A1 (es) 1982-06-01
JPS5745185A (en) 1982-03-13
IT8123026A0 (it) 1981-07-20
US4874869A (en) 1989-10-17
CH651568A5 (de) 1985-09-30
NL8103432A (nl) 1982-02-16
DK157301C (da) 1990-05-07
FR2487353A1 (fr) 1982-01-29
DK157301B (da) 1989-12-04
GB2080304A (en) 1982-02-03
DE3128606C2 (sv) 1992-04-23
FR2487353B1 (fr) 1986-03-07

Similar Documents

Publication Publication Date Title
SE8104456L (sv) Hydantoinderivat, sett for framstellning derav och lekemedel innehallande dem
ES473074A1 (es) Un procedimiento para la preparacion de derivados de tieno- tiacina
PT71306A (en) Process for preparing novel cyclic imidazole cyanoguanidines
JPS57193485A (en) 1-substituted-spiro(piperidine-oxobenzoxazine)s, manufacture and use for blood pressure fall
SE7901729L (sv) Ettiksyraderivat och sett for deras framstellning
ZA807819B (en) Benzothiazole derivatives, pharmaceutical formulations containing them and a process for their preparation
JPS5283396A (en) Novel compound physiologically acceptable salts thereof process for preparing same and medical composition containing same
DE3267188D1 (en) Hydroxybenzylamino-aryl compounds, process for preparing and pharmaceutical compositions containing the same
PT76614A (de) Thiomethylpyridin-derivate verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FI853233A0 (fi) 1,6-naftyridinderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska produkter.
ES8202818A1 (es) Un procedimiento para preparar derivados de tetrazolilcuma- rina
DE2962972D1 (en) 4-aminopyridines, process for their preparation and drugs containing them
DE3060236D1 (en) Thiazole derivatives, their preparation and medicaments containing them
SE8301785L (sv) Sett att framstella 2-tiofen-ettiksyraderivat och mellanprodukter erforderliga for deras framstellning
DE2962515D1 (en) Pyrano-heterocycles, process for their preparation and pharmaceutical compositions containing them
FR2456102B1 (sv)
AU6426386A (en) Derivatives of 3-imino-pyridazine, process for obtaining them and pharmaceutical compositions containing them
HUT43585A (en) Process for production of derivatives of piridine and medical compounds containing thereof
HUT44502A (en) Process for producing 3-amino-dihydropyridine derivatives and pharmaceutical compositions containing them
ES483138A1 (es) Un procedimiento para la preparacion de derivados de tieno- tiacina
GB2022075A (en) Lactam-N-acetic acids and the preparation thereof

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8104456-2

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8104456-2

Format of ref document f/p: F